Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caredx Inc
(NQ:
CDNA
)
23.21
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Caredx Inc
< Previous
1
2
3
4
5
6
7
8
Next >
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
March 23, 2023
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
March 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
March 07, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Update Regarding Raymond James & Associates’ Conference
March 06, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
March 06, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Comments on MolDX Publication of New Billing and Coding Article
March 03, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit
March 01, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Fourth Quarter and Full Year 2022 Results
February 27, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting
February 22, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings
February 16, 2023
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
February 13, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
January 26, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
January 11, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
January 09, 2023
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
December 30, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
December 21, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Announces $50 Million Stock Repurchase Program
December 06, 2022
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
December 05, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
December 01, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
November 11, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx To Participate in Upcoming Investor Conferences
November 04, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Third Quarter 2022 Results
November 03, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
November 02, 2022
From
CareDx, Inc.
Via
Business Wire
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
November 01, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
October 27, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Third Quarter 2022 Financial Results
October 26, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
October 26, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
October 25, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
September 29, 2022
From
CareDx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.